News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Wells Fargo's new $796 target sits just above Meta's own 52-week high

Wells Fargo just handed Meta a dramatically higher price target, and the reasoning behind it points to something bigger than a routine upgrade. Here is why one analyst believes the AI story at Meta is only getting started.

The Fed raised rates for the first time in three years, and bank stocks promptly sold off. What looks like a contradiction might be a warning about where the trade goes from here.

It's easy to be bullish about Argenx.

Shares of digital infrastructure provider Applied Digital (NASDAQ:APLD) jumped 6.8% in the afternoon session after Wells Fargo initiated coverage of the company with an Overweight rating and named the stock a top idea. According to TipRanks, the firm cited 1.4 gigawatts of contracted capacity and a power-advantaged footprint as key supports for the call. An Overweight rating typically means the analyst expects the shares to outperform peers over the firm’s investment horizon. For a capital-inten

Generac Holdings (NYSE:GNRC) shares surged 33. 7% in pre-market trading after the company announced a long-term agreement to supply industrial backup generators for Amazon’s global data centre infrastructure.

Can C's transformation, cost cuts and capital returns drive further upside despite its 29.3% six-month rally? Let us find out.

Everybody on Wall Street knows everything there is to know about popular mega-cap stocks, right? Matt Fruhan, a top fund manager of Fidelity Mega Cap Stock Fund, disagrees.

Wall Street remained split after RH’s Q2 earnings, with Wells Fargo backing its second-half growth drivers while UBS and BofA questioned growth estimates, according to TheFly.

Wells Fargo raises price target on Synopsys stock to $475. Here’s what made analyst Joe Quatrochi upgrade SNPS shares today.

TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.

According to the average brokerage recommendation (ABR), one should invest in Wells Fargo (WFC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Interest-rate strategists at Goldman Sachs Group Inc., Wells Fargo & Co. and other Wall Street firms said the US Treasury Department’s bond buybacks will do little to reverse the jump in long-term yields.

The US Treasury Department’s decision to boost buybacks of long-dated bonds is complicating the outlook for issuance of short-term securities, including Treasury bills, which are expected to be used to finance the plan.

C's 51.2% jump reflects a transformation gaining traction. Do its discounted valuation and rising earnings outlook leave room for upside? Let us find out.
Investing.com -- Fox Corp. was upgraded to Overweight from Neutral by J.P. Morgan and Wells Fargo, which also raised their price targets, citing stronger earnings prospects, robust advertising trends and the pending acquisition of Roku.

Wells Fargo (NYSE:WFC) just told its biggest clients they can move money on a Sunday. On August 4, the bank announced tokenized deposits, a blockchain-based version of commercial bank money that lets corporate and commercial clients settle funds 24/7/365 without ever leaving the insured banking system. It’s a quiet but telling move from a bank […]

There’s an elegant simplicity to one of the central tenets in gauging the health of the stock market and the companies that comprise its benchmark indexes: figuring out what’s in the till at the end of the day. Profit remains the most important measure of stock market health—and Corporate America is raking it in. “The greatest force behind stock markets right now is earnings, which is helping to overshadow concerns about Iran, inflation and AI [capital expenditure] spending viability,” said Dennis Follmer, chief investment officer, at Montis Financial in Waltham, Mass., to Barron’s. “Earnings have been an absolute freight train driving this market higher.”
C's record Q2 results, transformation plan and shareholder returns fuel optimism, but does its valuation still leave room for more upside? Let us find out.
(Bloomberg) -- Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, surged 67% on Friday after raising $128.7 million in an upsized initial public offering.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesSpaceX Turns Away Falcon Customers in Majo
Based on the average brokerage recommendation (ABR), Wells Fargo (WFC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Wells Fargo (WFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Truist Financial reports second-quarter earnings Friday, but investors may be more focused on what the leadership transition to incoming CEO Michael Lyons could mean for the bank’s strategy.
Wells Fargo’s chief financial officer said the firm was continuing to hit high levels of advisor recruiting and attrition each quarter, while Morgan Stanley is benefitting from IPO-related inflows.
